CytoRecovery

Improved system for cell separations used in cancer research.


(

Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9

CytoRecovery: Fast Facts

Problem

Samples of specific cell types are critical to study, diagnose and treat diseases like cancer and develop new therapeutics and vaccines.

But we need to sort and recover living cells from tumors and other tissue samples, especially rare cell types.

Introducing the next generation of cell recovery technology: CytoRecovery

Solution

The CytoRecovery Setup

We’ve developed a benchtop, commercial product system based on licensed Virginia Tech technology.

  • Cell separator chips
  • Chip holder
  • Frequency generator
  • Proprietary Reagents
  • Software for system control and sample analysis 

No new instrumentation is required for set-up; the system costs a fraction of the price of current platforms.

Research & Development

Meet The Team

Steve Turner, CHAIRMAN

  • Founded successful life science companies: BRL/Life Technologies, Oncor, OncorMed & Quorum
  • Former Director of Marketing at Microbiology Division of Becton Dickinson

Alex Hyler, Ph.D., CHIEF SCIENCE OFFICER (CSO)

  • PhD in biomedical engineering from Virginia Tech
  • Research focus on ovarian cancer biology, microfluidics, and device engineering.

Rafael Davalos, Ph.D., ADVISOR, CO-FOUNDER

  • Professor of Biomedical Engineering,  the Virginia Tech – Wake Forest University School of Biomedical Engineering and Sciences
  • Inventor of CytoRecovery cell separation technology platform

James Ramey, JD, BOARD MEMBER

  • Partner, VTC Innovation Fund

Eva Schmelz, Ph.D., ADVISOR 

  • Professor, Cell Biology, Virginia Tech
  • Field of research: cancer biology with the focus of cancer prevention 

David Sidransky, M.D., ADVISOR

  • Director of the Head and Neck Cancer Research Division at Johns Hopkins University School of Medicine
  • Founder of Champion Oncology and other successful biotech companies

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.


Request Access

N

No updates yet.




%

No backers yet.




Quick Signup TBD

You must have an account to do this!


the startups.com platform

Copyright © 2019 Startups.com. All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.